Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis

Weight gain, leading to further morbidity and poor treatment adherence, is a common consequence of treatment with antipsychotic drugs. Two recent studies in the same cohort of Chinese Han subjects have shown that polymorphisms of the promoter regions of both the serotonin 5-hydroxytryptamine 2C (5-H...

Full description

Saved in:

Bibliographic Details
Published in:	Pharmacogenetics and genomics Vol. 15; no. 4; p. 195
Main Authors:	Templeman, Lucy A, Reynolds, Gavin P, Arranz, Belen, San, Luis
Format:	Journal Article
Language:	English
Published:	United States 01.04.2005
Subjects:	Adult Affective Disorders, Psychotic - complications Affective Disorders, Psychotic - drug therapy Alleles Antipsychotic Agents - adverse effects Antipsychotic Agents - pharmacology Benzodiazepines - pharmacology Body Mass Index Female Genetic Variation Genotype Humans Leptin - blood Leptin - genetics Male Models, Genetic Olanzapine Pharmacogenetics Polymorphism, Genetic Promoter Regions, Genetic Receptor, Serotonin, 5-HT2C - genetics Receptors, Leptin Schizophrenia - drug therapy Time Factors Weight Gain - drug effects Weight Gain - genetics
ISSN:	1744-6872
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!